One method, taking advantage of tumor-specific promoters like that of survivin, may allow future studies to potentially direct the expression of other relevant apoptosis-inducing genes or apoptosis-inhibiting mutants in tumors. This evidence concerns the gene BIRC5 and neoplasm.